State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China

China

State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China

China

Time filter

Source Type

Dai Q.,State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China | Yin Q.,State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China | Wei L.,State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China | Zhou Y.,State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China | And 2 more authors.
Molecular Carcinogenesis | Year: 2015

Metabolic alteration in cancer cells is one of the most conspicuous characteristics that distinguish cancer cells from normal cells. In this study, we investigated the influence and signaling ways of oroxylin A affecting cancer cell energy metabolism under hypoxia. The data showed that oroxylin A remarkably reduced the generation of lactate and glucose uptake under hypoxia in HepG2 cells. Moreover, oroxylin A inhibited HIF-1α expression and its stability. The downstream targets (PDK1, LDHA, and HK II), as well as their mRNA levels were also suppressed by oroxylin A under hypoxia. The silencing or the overexpression of HIF-1α assays suggested that HIF-1α is required for metabolic effect of oroxylin A in HepG2 cells during hypoxia. Furthermore, oroxylin A could reduce the expression of complex III in mitochondrial respiratory chain, and then decrease the accumulation of ROS at moderate concentrations (0-50μM) under hypoxia, which was benefit for its inhibition on glycolytic activity by decreasing ROS-mediated HIF-1 expression. Besides, oroxylin A didn't cause the loss of MMP under hypoxia and had no obvious effects on the expression of OXPHOS complexes, suggesting that oroxylin A did not affect mitochondrial mass at the moderate stress of oroxylin A. The suppressive effect of oroxylin A on glycolysis led to a significantly repress of ATP generation, for ATP generation mostly depends on glycolysis in HepG2 cells. This study revealed a new aspect of glucose metabolism regulation of oroxylin A under hypoxia, which may contribute to its new anticancer mechanism. © 2015 Wiley Periodicals, Inc.

Loading State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China collaborators
Loading State Key Laboratory Of Natural Medicinesjiangsu Key Laboratory Of Carcinogenesis And Interventionkey Laboratory Of Drug Quality Control And Pharmacovigilanceministry Of Educationchina Pharmaceutical Universitynanjingpr China collaborators